Florida Atlantic University shattered all previous quarterly research records for a fiscal year by increasing actual research funding by 92% compared to the first three months of fiscal year 2019-2020. Florida Atlantic University investigators received $38.9 million from federal, state and private agencies for Q1 in the 2020-2021 fiscal period. For comparison, this figure for the same time period last year was $20.2 million. This marked growth occurred despite the fact that the state was severely impacted by the COVID-19 pandemic.
About Florida Atlantic University
Established in 1961, first opened its doors in 1964 as the fifth public university in the state. Based in Boca Raton, the university reports an annual economic impact of approximately $6.3 billion while serving over 30,000 undergraduate and graduate students at sites throughout the university’s six-county service region in southeast Florida. Florida Atlantic University is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. As part of its strategic plan, the university has research centers of excellence covering healthy aging, biotech, neuroscience, regenerative medicine, informatics as well as other scientific disciplines.
Florida Atlantic University biomedical research occurs in the Charles E. Schmidt College of medicine where investigational teams strive to develop innovative approaches to understand, treat and prevent disease in Palm Beach County, Florida and the rest of the nation as well as the world. With over 15,000 square feet of dedicated laboratory space and a wide variety of state-of-the-art equipment supported thanks to the Schmidt Family Endowment Fund and SU Excellence Funds, Research focus areas include:
· Healthy Aging, Geriatrics & Neuroscience (emphasis on cardiovascular disease, stroke, cancer, eye disease and neurodegenerative diseases)
· Chronic Pain & Opioid Use
· Genomics & Precision Medicine
The university’s faculty maintain affiliations with leading local research institutes such as Scripps Research Institute Florida as well as the Max Planck Florida Institute for Neuroscience.
A CNS-focused Center of Excellence
Just in 2018, the Lewy Body Dementia Association (LBDA) named Florida Atlantic University as a LBDA Research Center of Excellence (RCOE), a nationwide collaboration of 24 pre-eminent academic medical research centers. These centers are selected for their clinical expertise in LBD, experience conducting clinical trials, capacity of facilities and geographic location. This RCOE is housed in the Comprehensive Center for Brain Health led by James E. Galvin, MD, MPH, a world-renowned neuroscientist, a leading international expert on LBD and Alzheimer’s disease and associate dean for clinical research at Florida Atlantic University’s Charles E. Schmidt College of Medicine. Last year, Dr. Galvin and team were awarded $3 million for a dementia prevention initiative.
More Kudos for Top Researchers Here
Recently, the university informed the world that Lawrence Toll, PhD, professor of biomedical science in the Schmidt College of Medicine, and member of the university’s Brain Institute, was named by The Web of Science among its most Highly Cited Researchers.